This inventor holds 2 USPTO granted patents. Top assignees: National Jewis Center for Immunology and Respiratory Medicine, National Jewish Center for Immunology and Respiratory. Active years: 1993-1996.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Denver, CO (US) (1993)
- Aurora, CO (US) (1996)
Company Filing History:
Years Active: 1993-1996
Title: The Innovations of Stanley J Szefler
Introduction
Stanley J Szefler is a notable inventor based in Aurora, CO (US). He has made significant contributions to the field of immunology and respiratory medicine, holding 2 patents that focus on diagnosing and treating steroid-resistant inflammation.
Latest Patents
His latest patents include methods for diagnosing steroid-resistant inflammation due to type I. One patent discloses a method for diagnosing inflammation in an animal by analyzing cells to assess glucocorticoid receptor binding affinity or glucocorticoid receptor number. A low binding affinity and high receptor number are indicative of inflammation. Additionally, this patent outlines a method for treating inflammation in an animal, which involves suppressing the activity or expression of cytokines that alter glucocorticoid receptors. Another patent relates to treating a steroid-resistant condition via the administration of gamma interferon to alleviate symptoms associated with the condition.
Career Highlights
Stanley has worked at prominent institutions such as the National Jewish Center for Immunology and Respiratory Medicine. His work has significantly advanced the understanding of steroid-resistant inflammatory disorders.
Collaborations
Throughout his career, Stanley has collaborated with esteemed colleagues, including Donald Y Leung and Joseph D Spahn. Their combined expertise has contributed to the development of innovative treatments in the field.
Conclusion
Stanley J Szefler's contributions to immunology and respiratory medicine through his patents and collaborations highlight his role as a key innovator in addressing steroid-resistant inflammation. His work continues to impact the medical community positively.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile